Martha J. Carter is Chief Regulatory Officer at ALBIREO PHARMA, INC. (ALBO). They have made 4 open-market trades across 2 companies since 2012, most recently 2023-03-02.
CIK 0001213040
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $28K since 2012, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALBO | SELL · 10b5-1 | 2023-01-23 | 2023-01-23 | $43.80 | $5K | +1.8% | -0.6% | N/A |
| ALBO | SELL · 10b5-1 | 2023-01-19 | 2023-01-20 | $43.90 | $41K | +2.0% | -0.1% | N/A |
| ALBO | SELL · 10b5-1 | 2022-10-24 | 2022-10-25 | $19.58 | $2K | +8.2% | +10.4% | +119.7% |
| ALBO | SELL · 10b5-1 | 2022-07-22 | 2022-07-25 | $24.68 | $3K | +2.1% | -18.4% | -14.7% |
| ALBO | SELL · 10b5-1 | 2022-04-22 | 2022-04-25 | $32.92 | $3K | -7.1% | -39.7% | -30.2% |
| ALBO | SELL · 10b5-1 | 2022-01-24 | 2022-01-25 | $24.52 | $10K | +18.3% | +28.5% | +29.9% |
| ALBO | SELL | 2020-09-11 | 2020-09-15 | $40.03 | $400K | -17.6% | -15.1% | +1.5% |
| ALBO | SELL | 2020-09-08 | 2020-09-10 | $42.33 | $1.7M | -9.7% | -6.6% | -0.2% |
| AEGR | SELL · 10b5-1 | 2013-11-01 | 2013-11-05 | $82.81 | $414K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2013-01-23 | 2013-01-24 | $27.81 | $14K | -26.4% | -3.7% | -3.7% |
| AEGR | BUY | 2012-03-30 | 2012-04-02 | $14.03 | $14K | -26.4% | -3.7% | -3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.